معرفی
Dr. Amir Englund is a Research Fellow at the Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London, specializing in cannabinoid psychopharmacology. His work focuses on cannabis effects, harms, and medicinal applications, particularly the interplay between CBD and THC in cognitive, psychological, and physiological contexts.
- Key Research Themes: Cannabis safety, schizophrenia treatment, endocannabinoid system, addiction mechanisms, and neurophysiological effects
- Awards: American College of Neuropsychopharmacology (ACNP) NEATOR Award (2025)
- Collaborations: Works with Prof. Philip McGuire, Prof. Robin Murray, and Prof. Tara Peters on cannabis-related projects
Dr. Englund’s recent publications examine CBD’s role in schizophrenia treatment, attentional bias in cannabis users, and cannabis standardization. His work also intersects with UN Sustainable Development Goals related to health and well-being.
- Scientific Awards:
- ACNP NEATOR Award (2025) for transformative research on cannabis in schizophrenia
He contributes to policy and methodology through the iCannToolkit framework, while exploring pandemic-era implications for addiction research. His clinical trials involve collaborations with the NIHR Maudsley Biomedical Research Centre and the Centre for Pharmaceutical Medicine.
